ABSTRACT
In the past, feline infectious peritonitis (FIP) caused by feline coronavirus (FCoV) was considered fatal. Today, highly efficient drugs, such as GS-441524, can lead to complete remission. The currently recommended treatment duration in the veterinary literature is 84 days. This prospective randomized controlled treatment study aimed to evaluate whether a shorter treatment duration of 42 days with oral GS-441524 obtained from a licensed pharmacy is equally effective compared to the 84-day regimen. Forty cats with FIP with effusion were prospectively included and randomized to receive 15 mg/kg of GS-441524 orally every 24h (q24h), for either 42 or 84 days. Cats were followed for 168 days after treatment initiation. With the exception of two cats that died during the treatment, 38 cats (19 in short, 19 in long treatment group) recovered with rapid improvement of clinical and laboratory parameters as well as a remarkable reduction in viral loads in blood and effusion. Orally administered GS-441524 given as a short treatment was highly effective in curing FIP without causing serious adverse effects. All cats that completed the short treatment course successfully were still in complete remission on day 168. Therefore, a shorter treatment duration of 42 days GS-441524 15 mg/kg can be considered equally effective.
Subject(s)
Antiviral Agents , Coronavirus, Feline , Feline Infectious Peritonitis , Viral Load , Animals , Cats , Feline Infectious Peritonitis/drug therapy , Feline Infectious Peritonitis/virology , Prospective Studies , Coronavirus, Feline/drug effects , Female , Administration, Oral , Male , Antiviral Agents/administration & dosage , Antiviral Agents/therapeutic use , Viral Load/drug effects , Treatment Outcome , Adenosine/analogs & derivativesABSTRACT
Until recently, the diagnosis of feline infectious peritonitis (FIP) in cats usually led to euthanasia, but recent research has revealed that antiviral drugs, including the nucleoside analog GS-441524, have the potential to effectively cure FIP. Alpha-1-acid glycoprotein (AGP) has been suggested as a diagnostic marker for FIP. However, AGP quantification methods are not easily accessible. This study aimed to establish a Spatial Proximity Analyte Reagent Capture Luminescence (SPARCLTM) assay on the VetBio-1 analyzer to determine the AGP concentrations in feline serum and effusion samples. Linearity was found in serial dilutions between 1:2000 and 1:32,000; the intra-run and inter-run precision was <5% and <15%, respectively; and AGP was stable in serum stored for at least 8 days at room temperature, at 4 °C and at -20 °C. Cats with confirmed FIP had significantly higher serum AGP concentrations (median: 2954 µg/mL (range: 200-5861 µg/mL)) than those with other inflammatory diseases (median: 1734 µg/mL (305-3449 µg/mL)) and clinically healthy cats (median 235 µg/mL (range: 78-616 µg/mL); pKW < 0.0001). The AGP concentrations were significantly higher in the effusions from cats with FIP than in those from diseased cats without FIP (pMWU < 0.0001). The AGP concentrations in the serum of cats with FIP undergoing GS-441524 treatment showed a significant drop within the first seven days of treatment and reached normal levels after ~14 days. In conclusion, the VetBio-1 SPARCLTM assay offers a precise, fast and cost-effective method to measure the AGP concentrations in serum and effusion samples of feline patients. The monitoring of the AGP concentration throughout FIP treatment provides a valuable marker to evaluate the treatment's effectiveness and identify potential relapses at an early stage.
Subject(s)
Biomarkers , Feline Infectious Peritonitis , Luminescent Measurements , Animals , Cats , Female , Male , Antiviral Agents/therapeutic use , Biomarkers/blood , Coronavirus, Feline/isolation & purification , Feline Infectious Peritonitis/blood , Feline Infectious Peritonitis/diagnosis , Feline Infectious Peritonitis/drug therapy , Luminescent Measurements/methods , PrognosisABSTRACT
The conceptual structure of the aesthetics of objects was investigated. To this end, associative namings for the word "aesthetics" were collected from 311 nonartist German college students in a timed verbal association task. 590 different adjectives were produced, depicting diversification of the concept. The adjective "beautiful" was given by more than 90% of the participants. The adjective "ugly" was the second most frequent naming, used by almost half of the students. All other namings were markedly less frequently produced. It is argues that the beautiful-ugly dimension represents the primary concept in the aesthetics of objects, so that performing aesthetic judgments of the beauty of objects comes naturally to individuals. In other words, the most prototypical aesthetic judgments are those of beauty. Furthermore, the majority of generated words had a positive valence as measured by an additional valence-rating study including 41 participants. This result contrasts with comparable studies of emotion terms, as such studies typically show a negativity bias. Frequency in general language use and valence of the adjectives did not account for the results.